• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Stereotactic Radiotherapy (SRT) or Whole Brain Radiotherapy (WBRT) Alone versus SRT plus WBRT for Br

Stereotactic Radiotherapy (SRT) or Whole Brain Radiotherapy (WBRT) Alone versus SRT plus WBRT for Br

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：qinxinhun
【摘 要】
：
Objective: To perform ameta-analysis on diagnosed brain metastases patients treated with whole-brain radiotherapy (WBRT) and stereotactic radiotherapy (SRT) boost versus WBRT alone, or inpatients trea
【作 者】
：
Wenmei Su Zhennan Lai Lixia Li Yanming Lin Zhixiong Yang 
【机 构】
：
Department of Oncology, Affiliated Hospital of Guangdong Medical College
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年4期
【关键词】
：
Stereotactic radiotherapy whole brain radiotherapy 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective: To perform ameta-analysis on diagnosed brain metastases patients treated with whole-brain radiotherapy (WBRT) and stereotactic radiotherapy (SRT) boost versus WBRT alone, or inpatients treated with SRT alone versus WBRT and SRT boost.
其他文献
Identifying the Role of Protein kinase CK2 in the Radiosensitivity of Non-small Cell Lung Cancer
Objective: Proteinkinase CK2 (also known ascasein kinase) is a highlyconserved seine/threonine protein kinase, which is ubiquitously expressed inmammalian cells.CK2 has been implicated in multiple phy
会议
Protein kinase CK2RadiosensitivityNon small cell
Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma
Objective: Stem-like cells in solid tumors are purported to contribute to cancer development and poor treatment outcome.The abilities to self-renew, differentiate, and resist anticancer therapies are
会议
lung cancerstem cellvitamin D
Consolidation Chemotherapy may Improve Survival for Patients with Locally Advanced Non-small-cell Lu
Objective: For patients with locally advanced non-small-cell lung cancer (LA-NSCLC), the role of consolidation chemotherapy (CCT) following concurrent chemoradiotherapy (CRT) is partially defined.
会议
Locally advanced non-small-cell lung cancerConsol
CACNA2D1 Is a Novel Biomarker for Tumor Initiating Cells and Has Therapeutic Effect in Non-Small Cel
Objective: Tumor initiating cells (TICs) are a small subpopulation within cancer that is thought to be resistant to conventional therapiesand capable of reinitiating tumors.
会议
Tumor initiating cellsnon small lung cancertarg
Progression of central nervous system metastases in advanced non-small cell lung cancer effectively
Objective: Central nervous system (CNS) progression is frequently detected in patients with favorable initial responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs), but
会议
Non-small cell lung cancergefitinbcentral nervous
Genome-wide screen of DNA methylation changes reveals GABBR2 as a novel potential treatment target f
Objective: Lung cancer is the leading cause of cancer related death in the world.The last decade has witnessed the rapid development of epidermal growth factor receptor (EGFR) directed targeted therap
会议
lung adenocarcinomaepidermal growth factor receptor (EGFR)tyrosine kinase inhi
PD-L1 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small C
Objective: Although neoadjuvant chemotherapy (NAC) for advanced lung cancer can improve operability and local disease control, the duration of benefit is limited before resistance develops.
会议
PD L1chemoresistanceneoadjuvant therapy
Pooled analysis of CNS response to alectinib in two phase 2studies of pre-treated ALK+ NSCLC
Objective: The central nervous system (CNS) is a frequent site of progression in ALK+ NSCLC patients treated with crizotinib, thus good CNS efficacy is of crucial importance for new ALK inhibitors.
会议
alectinibCNS metastasisALK positive non small cell
Determining the prevalence of EGFR mutations in patients with advanced non-small-cell lung cancer (a
Objective: IGNITE (a large, multinational, diagnostic, non-comparative, interventional study;NCT01788163) assessed EGFR mutation frequency in patients with advanced NSCLC of adenocarcinoma (ADC)/non-A
会议
non-small-cell lung cancer
The role of postoperative adjuvant treatment in stageⅠB2/ⅡA2 cervical cancer patients with no pathol
目的： Bulky local tumor (≥4cm)is a poor prognostic factor for early stage cervical cancer patients.Most of the locally advanced cervical cancer patients need postoperative radiotherapy.
会议
cervical cancerlocally advanced stagerisk factor